TCL Archive In Brief: Durant Says He Expects Comprehensive Centers Lineup to Change With New System December 15, 1989
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004